Events

Cox to Speak at 2017 Global Technology Impact Forum

April 26, 2017
Paris, France

INPI (French Patent & Trademark Office)

Pamela Cox, Chair of Marshall Gerstein’s IP Transactions practice group, is a panelist at the 2017 Global Technology Impact Forum (GTIF) hosted by the Institut National de la Propriété Industrielle (INPI) in conjunction with World IP Day.

“Practical Implications of Socially-Responsible Licensing for Agreement Drafting”

Pamela Cox will join Gary Keller, CEO of Xomix, Magali Poinot, Advisor to the Executive Director at Innovative Medicines Initiative, and Julie Hutson, Legal Counsel at The Wellcome Trust, in a panel discussion, moderated by Julie Barnes-Weise, Executive Director of GHIAA, and contract drafting workshop focusing on the practical implications of global access and policy matters discussed at GTIF.

GTIF is a platform to discuss how IP and tech transfer are consistent with positive social and humanitarian endeavors across many sectors, including medicine, agriculture, energy, entrepreneurship, and start-ups. 

Pamela Cox concentrates on counseling related to intellectual property transactions, protection, and transfer for clients ranging from multinational corporations to non-profit institutions. As a patent attorney who has managed intellectual property portfolios in-house, Ms. Cox understands her clients’ intellectual property and agreement needs, and remains passionately engaged until achieving their strategic objectives. In addition to serving on the Board of Directors of Global Healthcare Innovation Alliance Accelerator (GHIAA), Ms. Cox is Chairman-elect to the Board of Governors of Certified Licensing Professionals (CLP), an international delegate for the Licensing Executives Society USA/Canada (LES), Past Chair and Advisor to the Life Science Committee for the Licensing Executive Society International (LESI) and Adjunct Professor at Northwestern University Pritzker Law School.

Offsite Notice

By clicking “Proceed” below, you will be opening a new browser window and leaving our website.